The only consistent association of FGFR1 abnormalities with cancer, however, involves the constitutive activation of a ligand-independent, chimeric FGFR1 kinase in Stem Cell Leukemia and Lymphoma syndrome (SCLL). The gene discussed is FGFR1; the disease is cancer.